Elsa Logarinho
Elsa Logarinho is Group leader in the Ageing and Aneuploidy Lab of the Instituto de Investigação em Saúde at Universidade do Porto. Elsa's lab uses human primary fibroblasts and induced pluripotent stem cells to study cellular phenotypes associated with normative aging, premature aging diseases and aneuploidy.
E. Logarinho concluded her PhD in Biomedical Sciences by the University of Porto (UP) in 2002. Under supervision of C.E. Sunkel at IBMC/UP, she studied the Polo/Plk1 and BubR1 mitotic kinases in Drosophila. After her PhD, E. Logarinho embraced a teaching position at the ISCS-N/CESPU Health Sciences School, while maintaining her research affiliation at IBMC. In 2007, E. Logarinho joined the Medical School/ICVS/UMinho as full-time Assistant Professor, and pursued her research in Mitosis, as well as contributed to several publications in other scientific areas. In 2009, E. Logarinho declined her professorship position and returned to full-time research career path under Ciência 2008 program, joining H. Maiato group at IBMC. Her work on mechanisms ensuring mitotic spindle-pole integrity (Nat Cell Biol 2012, 1st author) was acknowledged with an invited review in Nat Cell Biol 2014 (co-senior author) and Pfizer 2011 and SPGH 2013 prestigious national prizes.
In July 2013, she was awarded a Junior Researcher position funded by ON.2/QREN/FEDER to launch innovative research lines at IBMC (now part of the i3S Consortium/UP). Following a 2-year assessment period, she was highly recommended by the IBMC External Advisory Board for an independent research group status, and simultaneously awarded with a 5-year FCT Assistant Researcher position. Currently, her research group Aging & Aneuploidy is composed of 3 Post-Docs (started 2016, 2018, 2019) and 4 PhD students awarded with FCT fellowships (started 2016, 2017, 2018), working on to decipher mechanisms of mitotic dysfunction and aneuploidy contributing to aging and age-related diseases. Selected publications, out of 7 in the last 5 years with an average IF of 8.3, include as co-senior/senior author: Nat Cell Biol, Elife and Nat Commun. She successfully secured funding, presently coordinating 2 FCT projects and 2 tasks in a project granted to the Cancer Integrative Program of i3S (NORTE 2020). The originality of her work has caught international recognition shown by key international collaborations, the delivery of invited speaker/selected talks in prestigious meetings, peer reviewing and commissions of trust. She also collaborates with different groups at i3S, bridging Aging with all Integrative Programs. Besides her core scientific activities, E. Logarinho is regularly invited for UP meetings, doctoral programs and workshops, MSc/PhD theses exams, and actively involved in outreach activities. E. Logarinho h-index is of 17 (Scopus) as she co-authored 27 publications with 966 citations, including major multidisciplinary scientific journals.
E. Logarinho concluded her PhD in Biomedical Sciences by the University of Porto (UP) in 2002. Under supervision of C.E. Sunkel at IBMC/UP, she studied the Polo/Plk1 and BubR1 mitotic kinases in Drosophila. After her PhD, E. Logarinho embraced a teaching position at the ISCS-N/CESPU Health Sciences School, while maintaining her research affiliation at IBMC. In 2007, E. Logarinho joined the Medical School/ICVS/UMinho as full-time Assistant Professor, and pursued her research in Mitosis, as well as contributed to several publications in other scientific areas. In 2009, E. Logarinho declined her professorship position and returned to full-time research career path under Ciência 2008 program, joining H. Maiato group at IBMC. Her work on mechanisms ensuring mitotic spindle-pole integrity (Nat Cell Biol 2012, 1st author) was acknowledged with an invited review in Nat Cell Biol 2014 (co-senior author) and Pfizer 2011 and SPGH 2013 prestigious national prizes.
In July 2013, she was awarded a Junior Researcher position funded by ON.2/QREN/FEDER to launch innovative research lines at IBMC (now part of the i3S Consortium/UP). Following a 2-year assessment period, she was highly recommended by the IBMC External Advisory Board for an independent research group status, and simultaneously awarded with a 5-year FCT Assistant Researcher position. Currently, her research group Aging & Aneuploidy is composed of 3 Post-Docs (started 2016, 2018, 2019) and 4 PhD students awarded with FCT fellowships (started 2016, 2017, 2018), working on to decipher mechanisms of mitotic dysfunction and aneuploidy contributing to aging and age-related diseases. Selected publications, out of 7 in the last 5 years with an average IF of 8.3, include as co-senior/senior author: Nat Cell Biol, Elife and Nat Commun. She successfully secured funding, presently coordinating 2 FCT projects and 2 tasks in a project granted to the Cancer Integrative Program of i3S (NORTE 2020). The originality of her work has caught international recognition shown by key international collaborations, the delivery of invited speaker/selected talks in prestigious meetings, peer reviewing and commissions of trust. She also collaborates with different groups at i3S, bridging Aging with all Integrative Programs. Besides her core scientific activities, E. Logarinho is regularly invited for UP meetings, doctoral programs and workshops, MSc/PhD theses exams, and actively involved in outreach activities. E. Logarinho h-index is of 17 (Scopus) as she co-authored 27 publications with 966 citations, including major multidisciplinary scientific journals.